Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
irritable bowel syndrome (IBS)
Pharma
Takeda's Entyvio keeps its strong IBD position despite threats
With a new subcutaneous formulation for Entyvio, the company isn't worried about new entrants affecting its leading spot in the first-line IBD market.
Zoey Becker
Jul 31, 2024 4:43pm
API manufacturer Alchem accused by EC in price-fixing scheme
Jun 13, 2024 10:45am
Salix survey shows many IBS patients suffer in silence for years
Apr 5, 2023 10:25am
Bausch Health has been dealt a blow in its Xifaxan patent case
Jul 29, 2022 12:10pm
